UK Protection Insurance 2019: Critical Illness & Income Protection

UK Protection Insurance 2019: Critical Illness & Income Protection

Summary

This report focuses on the major (and closely related) IP and CI product lines. It examines the market size of both IP and standalone CI products with regards to the changes in new contracts and premiums written. It also examines the most frequent and expensive reason to claim on these policies. It highlights the most dominant players in the market and their propositions, and provides market sizing forecasts up to 2024. Finally, the report discusses how the market is likely to change, with a focus on technology as a key influencer.

Both the income protection (IP) and critical illness (CI) insurance markets experienced strong growth in 2018. Combined, they increased their share of the total protection market for the fourth year in a row, accounting for 10.2% of premiums in 2018. This indicates growing demand for illness- and injury-oriented products. The IP and CI markets remain locked in a dynamic where products are sold rather than bought; as a result, the advisory channel has remained the main way in which IP and CI products are distributed. But consistent growth is occurring in the non-advisory channel (to a greater extent in the CI market), which suggests that over the coming years we may see a shift towards products being bought rather than sold.

Scope

- The number of new contracts in the IP market increased in 2018 to 149,193, up 12.2% compared with the previous year.
- The standalone CI market experienced measured growth in 2018, with premiums and contracts increasing by 2.0% and 9.2% respectively.
- Legal & General was the largest provider of CI products in 2017, accounting for over a quarter of new contract sales in 2017.

Reasons to buy

- Understand the barriers of uptake for CI and IP, and learn how to increase consumer engagement.
- Explore how the distribution landscape is changing for these products.
- Discover who the leading providers of CI and IP are.
- See how the CI and IP markets are forecast to grow over the next five years.

1. EXECUTIVE SUMMARY
1.1. Market summary
1.2. Key findings
1.3. Critical success factors
2. MARKET DYNAMICS
2.1. Introduction
2.2. The total protection market grew in 2018
2.2.1. The growth rate of the total protection market slowed down in 2018
2.3. Growth in the IP and standalone CI markets slowed down in 2018
2.3.1. The share of IP and CI contracts in the total protection market has grown for the past four years
2.3.2. The IP market experienced subdued premium growth in 2018
2.3.3. UK households are being squeezed
2.3.4. The standalone CI market cooled down after two years of extremely strong growth
2.3.5. CI is much more popular when sold as a rider
2.3.6. The group life market experienced explosive growth in 2018
2.4. Cancer accounts for 63% of all CI claims paid
2.4.1. The average CI claim payment decreased by 2,000 but the total value of claims paid increased
2.4.2. Insurers should emphasize the frequency of successful claims in order to increase engagement with CI insurance
2.4.3. Mental health claims are the most expensive for IP products
2.4.4. IP policies with a shorter-term payout limit the cost of claims
3. DISTRIBUTION DYNAMICS
3.1. The advisory channels still dominate product distribution
3.1.1. The independent advice channel is still dominant but lost some ground in 2018
3.2. CI has seen continued growth in the non-advised channel
3.2.1. The independent advice channel saw the number of CI contracts fall in 2018
3.2.2. CI comparison sites will aid the advisory process
4. COMPETITOR DYNAMICS
4.1. The protection market is ruled by a small number of players
4.1.1. Legal & General and Aviva dominate the CI market
4.1.2. Aviva and Friends Life tie-up created a new market leader in the IP space
4.2. Competitor profiles for the leading CI and IP providers
4.2.1. Legal & Generals CI product gives policyholders access to a number of additional benefits
4.2.2. Legal & Generals IP product can be tailored to reduce premiums
4.2.3. Aviva offers two types of CI products to consumers tailored for different circumstances
4.2.4. Avivas Income Protection+ provides flexibility that allows product tailoring
4.2.5. LV=s CI product is only available as a rider alongside term life insurance
4.2.6. LV= offers three main types of IP products to consumers
4.2.7. Zurich launched a new protection platform in September 2018
4.2.8. Vitalitys cover operates on a severity scale when assessing claims
4.3. The complexity of CI and IP products hinders uptake
4.3.1. Hybrid CI and IP products may need to be developed
4.3.2. The number of conditions offered by the top CI providers varies considerably
5. THE FUTURE MARKET
5.1. The number of new IP contracts is expected to fall post-2021
5.1.1. IP premiums will rise slower than contracts from 2020-22
5.2. Both premiums and contracts will grow in the standalone CI market
5.2.1. By 2024, the number of standalone CI contracts is forecast to be 27% higher than in 2018
5.3. Insurers will use technology to develop more personalized products
5.3.1. Protection products will begin to incorporate the Internet of Things to change the focus to claims prevention
5.3.2. Insurers will collect data from multiple channels
5.3.3. Genome profiling could become widespread in the protection market
5.4. Digital services will be increasingly utilized
5.4.1. AI will help to streamline the claims process
5.4.2. Protection products will benefit from hybrid robo-advice
5.4.3. Remote consultations should be standard
6. APPENDIX
6.1. Abbreviations and acronyms
6.2. Bibliography
6.3. Further reading
6.4. Forecasting Methodology

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available